CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 35701-35943 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    As a guanosine analogue, extracellular favipiravir may bias the nucleotide pools, and favipiravir-RTP competes with GTP or ATP, resulting in an increase in the transition mutations, although data are not available to support this speculation.

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T189","span":{"begin":0,"end":242},"obj":"Sentence"}],"text":"As a guanosine analogue, extracellular favipiravir may bias the nucleotide pools, and favipiravir-RTP competes with GTP or ATP, resulting in an increase in the transition mutations, although data are not available to support this speculation."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T51","span":{"begin":0,"end":242},"obj":"Epistemic_statement"}],"text":"As a guanosine analogue, extracellular favipiravir may bias the nucleotide pools, and favipiravir-RTP competes with GTP or ATP, resulting in an increase in the transition mutations, although data are not available to support this speculation."}